Impact of a Gratitude-based Intervention in Palliative Care (IPBG)
IPBG
1 other identifier
interventional
50
1 country
3
Brief Summary
This is a pilot study consisting of mixed-methods, pre-post evaluation of a gratitude intervention (gratitude letter and visit) on palliative care patients and their caregivers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2018
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2018
CompletedFirst Posted
Study publicly available on registry
October 12, 2018
CompletedStudy Start
First participant enrolled
November 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 8, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 8, 2020
CompletedDecember 19, 2020
December 1, 2020
1.9 years
September 28, 2018
December 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in relationship quality for patients and caregivers
The quality of the relationship between the palliative patient and his/her caregiver will be measured with the Couple Satisfaction Index (CSI-4; "total score" range from 0 to 21, higher scores indicating a better quality of relationship).
Baseline approx. 5 days before intervention; post-intervention approx.10 days after intervention
Change in relationship quality for patients and caregivers
The quality of the relationship between the palliative patient and his/her caregiver will be also measured with the Positive Negative Relationship Quality Scale (PNRQ; "positive subscale" range from 0 to 48 and "negative subscale" range from 0 to 48, with higher scores indicating higher quality of relationship).
Baseline approx. 5 days before intervention; post-intervention approx.10 days after intervention
Secondary Outcomes (6)
Change in subjective quality of life for patients
Baseline approx. 5 days before intervention; post-intervention approx.10 days after intervention
Change in subjective quality of life for caregivers
Baseline approx. 5 days before intervention; post-intervention approx.10 days after intervention
Change in psychological distress for patients
Baseline approx. 5 days before intervention; post-intervention approx.10 days after intervention
Change in psychological distress for caregivers
Baseline approx. 5 days before intervention; post-intervention approx.10 days after intervention
Change in burden for patients
Baseline approx. 5 days before intervention; post-intervention approx.10 days after intervention
- +1 more secondary outcomes
Study Arms (1)
Gratitude intervention
EXPERIMENTALThe intervention will be proposed to both the patient and the caregiver and consists of two steps: the "gratitude letter" and the "gratitude visit". In the "gratitude letter", the individual writes about his feelings of gratitude through a letter, based on a written instruction. The "gratitude visit" consists of an extension of the gratitude letter where the writer of the letter (i) either personally reads the letter to the beneficent or (ii) gives it to him and asks him to read it in his presence or later in his absence.
Interventions
The intervention will be proposed to both the patient and the caregiver and consists of two steps: the "gratitude letter" and the "gratitude visit". In the "gratitude letter", the individual writes about his feelings of gratitude through a letter, based on a written instruction. The "gratitude visit" consists of an extension of the gratitude letter where the writer of the letter (i) either personally reads the letter to the beneficent or (ii) gives it to him and asks him to read it in his presence or later in his absence.
Eligibility Criteria
You may qualify if:
- Age \>18
- progressive disease
- reduced life expectancy
- enrolment in palliative care
- stable state for the previous 24h assessed by the physician or the nurse in charge of the patient
- informed consent signed by patient
- For each patient, the identification of a close family or friend caregiver (fulfilling the below criteria\*) and who accepts to participate in the trial (by signing an informed consent)
- In this research, a caregiver is defined as "a person who devotes time to help a family member or a friend affected in her/his health or autonomy. The caregiver assures, in a non-professional and regular way, a presence and a support to help her/him in his difficulties and assures her/his safety. The caregiver can be a friend, a family member or a neighbour" (Vaud canton definition). This definition will be the basis for the palliative patient to identify his caregiver.
You may not qualify if:
- Person completely isolated socially, no family or friend caregiver identified
- Significant cognitive or psychiatric disorders which would affect the ability to give informed consent for this research
- Severe communication problems (foreign language, deafness, etc.).
- Age \>18
- Identified as the caregiver by the palliative patient (see above)
- prior agreement of the patient for the participation of the caregiver
- Psychiatric and cognitive disorders which would affect the ability to give informed consent for this research based on the information reported by the clinical team in charge of the patient and the personal evaluation of the research collaborator.
- Communication problems (foreign language, deafness, etc.).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Rive-Neuve Foundation
Blonay, Canton of Vaud, 1807, Switzerland
Lausanne University hospital, Palliative and supportive care service
Lausanne, Canton of Vaud, 1011, Switzerland
Fribourg University hospital, Unité et Accueil de jour de soins palliatifs
Fribourg, 1708, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
Mathieu Bernard
Palliative and Supportive care service of the Centre Hospitalier Universitaire Vaudois
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of the Research Unit of the palliative and supportive care service
Study Record Dates
First Submitted
September 28, 2018
First Posted
October 12, 2018
Study Start
November 27, 2018
Primary Completion
October 8, 2020
Study Completion
October 8, 2020
Last Updated
December 19, 2020
Record last verified: 2020-12